Europe Pharma News 2/4

top of page

iPharmaCenter

News | Blogs | Healthcare | Consulting

Contact: info@ipharmacenter.com

Home
Pharma
Healthcare News
Healthcare Policies
Disease News
Conferences
Others
- COVID-19
- Contact

Search

CHMP Positive Opinions | EMA Drug Approvals | European Commission | 2023 | iPharmaCenter

CHMP Positive Opinions | EMA Drug Approvals | European Commission | 2023 | iPharmaCenter

ipharmaservices

Jul 26, 2023

0

Switzerland drug approvals | Swissmedic news | Blogs | 2023 | iPharmaCenter

ipharmaservices

Jul 10, 2023

0

Medicines and Healthcare products Regulatory Agency | News | 2023 Approvals | iPharmaCenter

Medicines and Healthcare products Regulatory Agency | News | 2023 Approvals | iPharmaCenter

ipharmaservices

May 16, 2023

0

2022 | CHMP Positive Opinions | EMA Drug Approvals | European Commission | Pharma | News

2022 | CHMP Positive Opinions | EMA Drug Approvals | European Commission | Pharma | News

ipharmaservices

Feb 28, 2023

0

Drug approvals in Europe| EMA drug approvals in 2022 |European Commission News| iPharmaCenter

Drug approvals in Europe| EMA drug approvals in 2022 |European Commission News| iPharmaCenter

ipharmaservices

Jan 26, 2023

0

France healthcare News | HAS Sante | COVID 19 | Drug approvals | iPharmaCenter

France healthcare News | HAS Sante | COVID 19 | Drug approvals | iPharmaCenter

ipharmaservices

Jan 6, 2023

0

COVID19 drug updates | FDA EMA approved COVID19 drugs

COVID19 drug updates | FDA EMA approved COVID19 drugs

ipharmaservices

Oct 9, 2022

0

Opdualag was approved for unresectable/metastatic melanoma | LAG-3 inhibitors | Mode of action

ipharmaservices

Sep 19, 2022

0

European Commission approved Scemblix for chronic myeloid leukemia | iPharmaCenter

European Commission approved Scemblix for chronic myeloid leukemia | iPharmaCenter

ipharmaservices

Aug 29, 2022

0

Roche’s Polivy was approved as first-line therapy for patients with DLBCL.

Roche’s Polivy was approved as first-line therapy for patients with DLBCL.

ipharmaservices

May 25, 2022

0

Germany HTA News | IQWIG and G-BA assessment news | Germany Pharma News

Germany HTA News | IQWIG and G-BA assessment news | Germany Pharma News

ipharmaservices

Dec 9, 2021

0

European Commission approved Roche's and Celltrion's monoclonal antibodies for COVID19

European Commission approved Roche's and Celltrion's monoclonal antibodies for COVID19

ipharmaservices

Nov 21, 2021

0

European Commission approved Benlysta for active lupus nephritis

European Commission approved Benlysta for active lupus nephritis

ipharmaservices

May 9, 2021

0

France COVID-19 Updates | COVID-19 News in Europe

France COVID-19 Updates | COVID-19 News in Europe

ipharmaservices

May 4, 2021

0

GSK’s Jemperli received approval in Europe and the US for endometrial cancer

GSK’s Jemperli received approval in Europe and the US for endometrial cancer

ipharmaservices

Apr 23, 2021

0

England patients to benefit from Phesgo, 5-minute breast cancer treatment from Roche

England patients to benefit from Phesgo, 5-minute breast cancer treatment from Roche

ipharmaservices

Apr 7, 2021

0

CHMP Opinions | EMA drug approvals

CHMP Opinions | EMA drug approvals

ipharmaservices

Mar 29, 2021

0

Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio

Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio

ipharmaservices

Jan 12, 2021

0

Biogen initiated Phase 4 trial to determine the efficacy of Spinraza in Zolgensma treated patients

ipharmaservices

Jan 12, 2021

0

Kite’s CAR-Tcell therapy received approval in Europe for relapsed or refractory mantle cell lymphoma

ipharmaservices

Dec 28, 2020

0

For sponsored articles, link insertions, and advertisements, please write to info@ipharmacenter.com

Find the latest pharma and healthcare news on Telegram now. Simply scan the QR code.

Rephrase with Ginger (Cmd+⌥+E)

iPharmaCenter Telegran_edited.jpg

bottom of page